Vivani Medical (VANI) Non-Current Assets (2014 - 2026)
Vivani Medical (VANI) posted quarterly Non-Current Assets of $20.8 million for Q1 2026, up 247.03% year-over-year from $6.0 million in Q1 2025, and down 3.21% quarter-over-quarter from $21.5 million in Q4 2025.
Vivani Medical (VANI) Non-Current Assets (2014 - 2026) Analysis & Trends
Vivani Medical's Non-Current Assets history runs 13 years deep, the most recent figure standing at $20.8 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 247.03% year-over-year to $20.8 million; the TTM figure through Mar 2026 stood at $83.4 million (up 65.55% YoY), while the FY2025 annual figure was $21.5 million, up 1.78% from the prior year.
- Non-Current Assets for Q1 2026 stood at $20.8 million, down from $21.5 million in the prior quarter.
- The five-year high for Non-Current Assets was $23.4 million in Q2 2023, with the low at -$14.2 million in Q1 2025.
- The 5-year median for Non-Current Assets is $20.9 million (2025), against an average of $14.8 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 1628.03% in 2022, then slumped 163.49% in 2025.
- Vivani Medical's Non-Current Assets stood at $3.6 million in 2022, then jumped by 531.18% to $22.7 million in 2023, then decreased by 7.11% to $21.1 million in 2024, then grew by 1.78% to $21.5 million in 2025, then decreased by 3.21% to $20.8 million in 2026.
- Business Quant data shows VANI's Non-Current Assets at $20.8 million in Q1 2026, $21.5 million in Q4 2025, and $20.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 20.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.00 Mn |
| Mar 31, 2026 | 20.81 Mn |
| Dec 31, 2025 | 21.50 Mn |
| Sep 30, 2025 | 20.87 Mn |
| Jun 30, 2025 | 20.19 Mn |
| Mar 31, 2025 | -14.15 Mn |
| Dec 31, 2024 | 21.12 Mn |
| Sep 30, 2024 | 21.50 Mn |
| Jun 30, 2024 | 21.89 Mn |
| Mar 31, 2024 | 22.29 Mn |
| Dec 31, 2023 | 22.74 Mn |
| Sep 30, 2023 | 22.64 Mn |
| Jun 30, 2023 | 23.39 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 3.60 Mn |
| Sep 30, 2022 | 2.56 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 8.32 Mn |
| Dec 31, 2021 | 2.98 Mn |
| Sep 30, 2021 | 409,000.00 |